High-flow Nasal Oxygen in Palliative Care: Pilot Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Dyspnea
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Pilot study for acceptability of high flow nasal cannula oxygen therapy in palliative care Population: 30 patients in palliative care (for lung cancer, terminal respiratory failure) who suffer from dyspnea and have oxygen therapy. Patients with curative care are excluded and patients who require non...
Pilot study for acceptability of high flow nasal cannula oxygen therapy in palliative care Population: 30 patients in palliative care (for lung cancer, terminal respiratory failure) who suffer from dyspnea and have oxygen therapy. Patients with curative care are excluded and patients who require non invasive ventilation. An oral consent is asked. Primary objective: acceptability of HNFC in patients with dyspnea in palliative care during one week Secondary objectives: Tolerance of HNFC at short term (1h and 24h) and long term (7 days) after initiation of HNFC Efficiency of HNFC at short term Primary outcome: duration of use of the HNFC during 7 days Secondary outcome: Tolerance: noise of the system of HNFC, side effects of high flow (nasal dryness..) Efficiency: evaluation of dyspnea by Borg scale and measure of respiratory rate and saturation of oxygen one hour after initiation of HNFC
Tracking Information
- NCT #
- NCT03423888
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Marion DUPUIS, MD University Hospital, Toulouse
Get Well Soon